Why the study?
COVID-19 causes cardiovascular damage, but the pathophysiological mechanisms are not fully understood.
Key points are not available for this paper at this time.
Design
Review article
Alerts clinicians to monitor post-COVID cardiovascular risks; leaves open optimal targeted therapies pending higher-level evidence.
Like other respiratory viruses, COVID-19 has extrapulmonary manifestations. The effect of the virus leads to the cardiovascular system (CVS) damage in particular, which pathophysiological mechanisms are not fully understood. In this article we analyze modern ideas about COVID-19, consider possible links of pathogenesis, make an attempt to systematize pathophysiological mechanisms of cardiovascular impairment and its complications, analyze the relation with cardiovascular comorbidity, describe pathomorphological features and discuss possible long-term prognosis. The information in this article can contribute to understanding the two-way interaction of cardiovascular diseases and the effects of COVID-19 in order to develop effective preventive measures and make the right decision in choosing therapeutic tactics for a patient.
No takes yet. Share an insight, caveat, or question.
Петриков et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: